Back
ProShares MSCI EAFE Dividend Growers ETF Vs. Denali Therapeutics, Inc. Industry Stock Comparison
Buy
52
EFAD
ProShares MSCI EAFE Dividend Growers ETF
Last Price:
$42.10
Seasonality Move:
-1.04%
Sell
45
DNLI
Denali Therapeutics, Inc.
Last Price:
$17.01
Seasonality Move:
-13.05%
Buy
52
ProShares MSCI EAFE Dividend Growers ETF (EFAD)
is a Buy
Is ProShares MSCI EAFE Dividend Growers ETF a Buy, Sell or Hold?
-
The current ProShares MSCI EAFE Dividend Growers ETF [EFAD] share price is $41.86. The Score for EFAD is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
EFAD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Denali Therapeutics, Inc. (DNLI)
is a Sell
Is Denali Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Denali Therapeutics, Inc. [DNLI] share price is $16.99. The Score for DNLI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EFAD Stock Price Chart
What is ProShares MSCI EAFE Dividend Growers ETF's stock price today?
-
The ProShares MSCI EAFE Dividend Growers ETF share price today is $41.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EFAD is experiencing slight selling pressure.
DNLI Stock Price Chart
What is Denali Therapeutics, Inc.'s stock price today?
-
The Denali Therapeutics, Inc. share price today is $16.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
EFAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 48.33 | Sell |
| Chaikin Money Flow: | 54 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.38 - 42.2) | Buy |
| Bollinger Bands (100): | (41.66 - 42.56) | Sell |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 45.62 | Sell |
| Chaikin Money Flow: | 334081 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.97 - 19.23) | Sell |
| Bollinger Bands (100): | (14.19 - 17.65) | Buy |
EFAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42 | Sell |
| 20-day SMA: | 41.98 | Sell |
| 50-day SMA: | 41.95 | Sell |
| 200-day SMA: | 41.59 | Buy |
| 8-day EMA: | 41.98 | Sell |
| 20-day EMA: | 41.94 | Sell |
| 50-day EMA: | 41.96 | Sell |
| 200-day EMA: | 41.45 | Buy |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.01 | Sell |
| 20-day SMA: | 18.11 | Sell |
| 50-day SMA: | 17.22 | Sell |
| 200-day SMA: | 15.06 | Buy |
| 8-day EMA: | 17.19 | Sell |
| 20-day EMA: | 17.55 | Sell |
| 50-day EMA: | 17.12 | Sell |
| 200-day EMA: | 16.66 | Buy |
ProShares MSCI EAFE Dividend Growers ETF Earnings Growth & EFAD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Denali Therapeutics, Inc. Earnings Growth & DNLI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.04 per share.
ProShares MSCI EAFE Dividend Growers ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||